VolitionRx Limited Effective Income Tax Rate Reconciliation, Tax Settlement, Amount
VolitionRx Limited (VNRX) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Amount of $904.81 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-10.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxSettlements · last filed 2017-03-10
- VolitionRx Limited effective income tax rate reconciliation, tax settlement, amount for fiscal 2016 was $904.81K, a 19.75% increase from fiscal 2015.
- VolitionRx Limited effective income tax rate reconciliation, tax settlement, amount for fiscal 2015 was $755.55K, a 29.54% decline from fiscal 2014.
- VolitionRx Limited effective income tax rate reconciliation, tax settlement, amount for fiscal 2014 was $1.07M, a 322.24% increase from fiscal 2013.
- VolitionRx Limited effective income tax rate reconciliation, tax settlement, amount for fiscal 2013 was $253.94K, a 76.56% decline from fiscal 2012.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Amount 12 month |
|---|---|
| 2016-12-31 | $904.81K 10-K · filed 2017-03-10 |
| 2015-12-31 | $755.55K 10-K · filed 2017-03-10 |
| 2014-12-31 | $1.07M 10-K · filed 2016-03-11 |
| 2013-12-31 | $253.94K 10-K · filed 2015-03-18 |
| 2012-12-31 | $1.08M 10-K · filed 2014-03-28 |
| 2011-12-31 | $310.66K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |